Impact of Concentrated Growth Factors on osseointegration and implant stability: a Clinico-radigraphic study

A clinico-radiographic comparison of the osteointegration of implants placed with and without concentrated growth factors. a randomized controlled trial. - NIL

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/107951

Enrollment

Registered

2026-04-09

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: CONTROL GROUP: CONTROL GROUP Intervention2: Concentrated Growth Factor (CGF): Implant placement with concentrated growth factor. Control Intervention1: Concentrated Growth Factor (CGF):

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient with age group between 18-60 years. 2. Patients who are cooperative, motivated, and have good oral hygiene. 3. Patients who are systemically healthy. 4. Patients who have adequate bone dimensions, at edentulous site for implant placement. 5. Patients who are willing and will be available for recall and follow-ups.

Exclusion criteria

Exclusion criteria: 1. Patients with any systemic diseases that contraindicates implant placement. 2. Patients who have blood disease that prevent centrifugation. 3. Patients who need advanced surgical procedure for implant placement. 4. Patients who had previous implantation or augmentation in the same region. 5. Patients who are current / ex- smokers or consume any form of tobacco 6. Patients who are allergic to one of the materials to be used in the procedure.

Design outcomes

Primary

Measure	Time frame
. Implant stability: a. Insertion Torque value b. Implant Stability Quotient 2. Marginal bone loss. Timepoint: Baseline, 4 weeks ,12 weeks and 6 months	—

Secondary

Measure	Time frame
1. Plaque index (PI) 2. Gingival index (GI) 3. Tissue biotype assessment Timepoint: baseline, 4 weeks ,12 weeks & 6 months	—

Countries

India

Contacts

Public ContactGINNI

PGIDS, ROHTAK

drshalinigugnani@gmail.com9466949150

Outcome results